Repligen stockRGEN
Repligen trades at $168.48, 15.3% below its 52-week high (Sep 28, 2026). The price is below its 50-day but above its 200-day average: a pullback within an uptrend. +2.8% year to date, +15.5% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Feb 24, 2027.
No news on Repligen today. Its industry peers (Medical Instruments & Supplies) that day: “Envista delays expected China rebound to 1H 2027, guides Q4 core growth flat-to-down after Q3 beat”.
All moves of the day →Ratings, candles, signals and the screener for RGEN — after you log in
Open the terminalFrequently asked questions about Repligen
What is the Repligen stock price?
At the close on Nov 5, 2026: $168.48 (−5.45% on the day). 52-week high: $198.87 on Sep 28, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Repligen report earnings?
The next quarterly report is on Feb 24, 2027. Last quarter, earnings per share changed +15% year over year, revenue +11%.
Does Repligen pay dividends?
No, Repligen does not pay dividends.
Where does Repligen trade and how to buy it?
Ticker RGEN, exchange Nasdaq, listed since 1986. You can buy it through a broker with access to US exchanges.
Should I buy Repligen now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for RGEN are in the terminal after you log in.